Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT05979909 2023-08-07

Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma

Phase 1 Not yet recruiting

40 enrolled

Genitourinary

Urothelial Carcinoma Ureter

NCT05698238 2023-03-15

CAMP1

Phase 1 Not yet recruiting

50 enrolled

BreastGenitourinaryHead & NeckOther solid neoplasmThoracic

Clear-cell metastatic renal cell carcinoma, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

Ultra-hypofractionated Carbon-ion Therapy for Prostate Cancer

SWAP

Lutécio

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

CALCIFER

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

JL19001-NMIBC

A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer

CALySSEY

PERSEVERANCE

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study

Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

LumOnate

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors

Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma

CAMP1